Neoplasms Metastasis Completed Phase 1 Trials for Olaparib (DB09074)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00633269Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic TumoursTreatment
NCT00710268Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid TumoursTreatment